Liquidia (LQDA) Projected to Post Quarterly Earnings on Monday

Liquidia (NASDAQ:LQDA) will likely be announcing its Q3 2025 results before the market opens on Monday, November 3rd. Analysts expect the company to announce earnings of ($0.45) per share and revenue of $18.8580 million for the quarter. Investors may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Monday, November 3, 2025 at 8:30 AM ET.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Tuesday, August 12th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.43) by ($0.06). Liquidia had a negative return on equity of 232.96% and a negative net margin of 732.17%.The firm had revenue of $8.84 million for the quarter, compared to analysts’ expectations of $3.90 million. The company’s revenue for the quarter was up 141.5% compared to the same quarter last year. On average, analysts expect Liquidia to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Liquidia Stock Up 5.0%

Shares of LQDA opened at $24.36 on Friday. The company has a debt-to-equity ratio of 9.84, a quick ratio of 2.41 and a current ratio of 2.49. Liquidia has a one year low of $9.71 and a one year high of $29.94. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of -14.33 and a beta of 0.15. The stock has a 50 day moving average price of $24.61 and a 200 day moving average price of $19.35.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Jefferies Financial Group initiated coverage on Liquidia in a report on Friday, August 15th. They set a “buy” rating and a $43.00 price target for the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a research report on Wednesday, October 8th. Wells Fargo & Company started coverage on shares of Liquidia in a report on Monday, October 20th. They issued an “overweight” rating and a $31.00 target price on the stock. Raymond James Financial boosted their target price on Liquidia from $33.00 to $41.00 and gave the company a “strong-buy” rating in a report on Wednesday, August 13th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $35.00 price objective on shares of Liquidia in a report on Monday, October 6th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $32.38.

Insider Activity at Liquidia

In other news, General Counsel Russell Schundler sold 7,839 shares of the stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $23.41, for a total value of $183,510.99. Following the completion of the sale, the general counsel owned 576,017 shares in the company, valued at approximately $13,484,557.97. This trade represents a 1.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Scott Moomaw sold 4,900 shares of the firm’s stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $23.41, for a total value of $114,709.00. Following the sale, the insider owned 153,462 shares of the company’s stock, valued at approximately $3,592,545.42. This trade represents a 3.09% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 879,141 shares of company stock valued at $24,184,920 over the last three months. Insiders own 26.50% of the company’s stock.

Institutional Trading of Liquidia

Several hedge funds have recently added to or reduced their stakes in LQDA. Advisory Services Network LLC grew its holdings in shares of Liquidia by 13.2% in the 2nd quarter. Advisory Services Network LLC now owns 76,065 shares of the company’s stock worth $948,000 after acquiring an additional 8,885 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in Liquidia by 281.2% during the second quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock valued at $83,000 after purchasing an additional 4,927 shares during the last quarter. Exome Asset Management LLC acquired a new stake in Liquidia during the second quarter valued at $255,000. Oxford Asset Management LLP acquired a new stake in Liquidia during the second quarter valued at $373,000. Finally, Opaleye Management Inc. boosted its position in Liquidia by 9.5% during the second quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company’s stock valued at $30,838,000 after purchasing an additional 215,000 shares during the last quarter. Institutional investors own 64.54% of the company’s stock.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).